In the @-patient trial , more levosimendan than placebo patients ( @ vs. @ ) were improved at all @ pre-specified time points ( @ h , @ h , and @ days ) , whereas fewer levosimendan patients ( @ vs. @ ) experienced clinical worsening ( p = @ for the difference between the groups ) .